Best-in-class facilities and capabilities have been established at BRI to drive breakthrough research and drug discovery. Our research activities also receive support from the Biosciences Central Research Facility at HKUST. Various platforms for optical imaging, electrophysiological tests, animal behavior assessments, proteomics, genomics, transgenic studies, and high-throughput screening are available to facilitate development of TCM-derived therapeutics for neurological disorders.